Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Cancers|May 14, 2022
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell NeoplasmElodie Bôle-Richard, Naveen Pemmaraju, Blandine Caël, et al.Current Hematologic Malignancy Reports|October 25, 2017
Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCNNaveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.Clinical Lymphoma, Myeloma & Leukemia|July 9, 2019
Blastic Plasmacytoid Dendritic Cell Neoplasm-Current InsightsSangeetha Venugopal, Selena Zhou, Siraj M El Jamal, et al.American Journal of Hematology|June 17, 2025
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 2025 Update on Diagnosis, Pathophysiology, Risk Assessment, and ManagementShai Shimony, Marlise R Luskin, Naseema Gangat, et al.Blood|July 22, 2010
A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemiaGeoffrey L Uy, Andrew A Lane, John S Welch, et al.Blood|March 21, 2018
Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cellsWen Hao Neo, Christopher A G Booth, Emanuele Azzoni, et al.Blood Advances|April 11, 2024
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survivalShai Shimony, Julia Keating, Christopher J Fay, et al.Journal of Autoimmunity|September 26, 2017
Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) geneMindy S Lo, Meghan Towne, Grace E VanNoy, et al.Blood Advances|October 30, 2023
AMPK activation induces immunogenic cell death in AMLJohanna Mondesir, Margherita Ghisi, Laura Poillet, et al.Blood Advances|January 4, 2018
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screeningMarlise R Luskin, Marie N Discenza, Sarah Rae Easter, et al.Pageof 10